• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞动员过程中微小RNA表达的变化

Alterations in microRNA Expression during Hematopoietic Stem Cell Mobilization.

作者信息

Nowicki Mateusz, Szemraj Janusz, Wierzbowska Agnieszka, Pluta Agnieszka, Grzybowska-Izydorczyk Olga, Nowicka Aleksandra, Stelmach Piotr, Czemerska Magdalena, Szmigielska-Kapłon Anna

机构信息

Department of Hematology, Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology, 93-513 Łódź, Poland.

Department of Medical Biochemistry, Medical University of Lodz, 92-215 Łódź, Poland.

出版信息

Biology (Basel). 2021 Jul 15;10(7):668. doi: 10.3390/biology10070668.

DOI:10.3390/biology10070668
PMID:34356523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8301406/
Abstract

microRNAs play an important role in the regulation of gene expression, cell fate, hematopoiesis, and may influence the efficacy of CD34+ cell mobilization. The present study examines the role of hsa-miR-15a-5p, hsa-miR-16-5p, hsa-miR-34a-5p, hsa-miR-126-3p, hsa-miR-146a-5p, hsa-miR-155-5p, and hsa-miR-223-3p in the course of hematopoietic stem cell mobilization. The numbers of CD34+ cells collected in patients with hematological malignancies (39 multiple myelomas, 11 lymphomas) were determined during mobilization for an autologous hematopoietic stem cell transplantation. The miRNA level was evaluated by RT-PCR. Compared to baseline, a significant decline in hsa-miR-15a-5p, hsa-miR-16-5p, hsa-miR-126-3p, hsa-miR-146a-5p, and hsa-miR-155-5p was observed on the day of the first apheresis (day A). An increase was observed only in the expression of hsa-miR-34a-5p. On day A, a negative correlation was found between hsa-miR-15a-5p and hsa-miR-146a-5p levels and the number of CD34+ cells in peripheral blood. A negative correlation was observed between hsa-miR-146a-5p and the number of collected CD34+ cells after the first apheresis. Good mobilizers, defined according to GITMO criteria, demonstrated a lower hsa-miR-146a-5p level on day A than poor mobilizers. Patients from the hsa-miR-146a-5p "low expressors" collected more CD34+ cells than "high expressors". Our results suggest that the investigated miRNAs, especially hsa-miR-146a-5p, may influence the efficacy of HSC mobilization.

摘要

微小RNA在基因表达调控、细胞命运决定、造血过程中发挥着重要作用,并且可能影响CD34+细胞动员的效果。本研究探讨了hsa-miR-15a-5p、hsa-miR-16-5p、hsa-miR-34a-5p、hsa-miR-126-3p、hsa-miR-146a-5p、hsa-miR-155-5p和hsa-miR-223-3p在造血干细胞动员过程中的作用。在进行自体造血干细胞移植动员期间,测定了血液系统恶性肿瘤患者(39例多发性骨髓瘤、11例淋巴瘤)采集的CD34+细胞数量。通过逆转录聚合酶链反应评估微小RNA水平。与基线相比,在首次单采术当天(A日)观察到hsa-miR-15a-5p、hsa-miR-16-5p、hsa-miR-126-3p、hsa-miR-146a-5p和hsa-miR-155-5p显著下降。仅观察到hsa-miR-34a-5p的表达增加。在A日,hsa-miR-15a-5p和hsa-miR-146a-5p水平与外周血中CD34+细胞数量之间存在负相关。在首次单采术后,观察到hsa-miR-146a-5p与采集的CD34+细胞数量之间存在负相关。根据全球造血干细胞动员组织(GITMO)标准定义的良好动员者在A日的hsa-miR-146a-5p水平低于不良动员者。来自hsa-miR-146a-5p“低表达者”的患者比“高表达者”采集到更多的CD34+细胞。我们的结果表明,所研究的微小RNA,尤其是hsa-miR-146a-5p,可能影响造血干细胞动员的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/5260cee5c0d9/biology-10-00668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/f7f54c83399f/biology-10-00668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/a7076fef5323/biology-10-00668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/965b4ff16eb7/biology-10-00668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/5260cee5c0d9/biology-10-00668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/f7f54c83399f/biology-10-00668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/a7076fef5323/biology-10-00668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/965b4ff16eb7/biology-10-00668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dcc/8301406/5260cee5c0d9/biology-10-00668-g004.jpg

相似文献

1
Alterations in microRNA Expression during Hematopoietic Stem Cell Mobilization.造血干细胞动员过程中微小RNA表达的变化
Biology (Basel). 2021 Jul 15;10(7):668. doi: 10.3390/biology10070668.
2
Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.登革热感染患者血清微小RNA谱失调及潜在生物标志物
Int J Med Sci. 2016 Feb 18;13(3):195-205. doi: 10.7150/ijms.13996. eCollection 2016.
3
MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis.微小 RNA-132、miR-146a 和 miR-155 作为类风湿关节炎患者甲氨蝶呤反应的潜在生物标志物。
Clin Rheumatol. 2019 Mar;38(3):877-884. doi: 10.1007/s10067-018-4380-z. Epub 2018 Dec 3.
4
Circulating microRNA alternations in primary hyperuricemia and gout.原发性高尿酸血症和痛风患者循环 microRNA 的变化。
Arthritis Res Ther. 2021 Jul 10;23(1):186. doi: 10.1186/s13075-021-02569-w.
5
Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.肺癌患者外周血中 miRNA 差异表达谱分析。
J Clin Lab Anal. 2019 Nov;33(9):e23003. doi: 10.1002/jcla.23003. Epub 2019 Sep 20.
6
MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation.微小RNA可预测自体造血干细胞移植的早期并发症。
Biomark Res. 2024 Apr 23;12(1):42. doi: 10.1186/s40364-024-00585-x.
7
MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.配对的原发性和淋巴结转移性乳腺癌的MicroRNA表达谱分析揭示了与淋巴结转移相关的独特MicroRNA谱。
Front Oncol. 2020 May 19;10:756. doi: 10.3389/fonc.2020.00756. eCollection 2020.
8
Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients.范可尼贫血患者骨髓间充质干细胞的全球 miRNA 表达。
Hum Cell. 2022 Jan;35(1):111-124. doi: 10.1007/s13577-021-00626-9. Epub 2021 Nov 18.
9
miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment.miRNA-15a、miRNA-16、miRNA-126、miRNA-146a 和 miRNA-223 在自体造血干细胞移植中的表达及其对植入的影响。
Eur J Haematol. 2018 May;100(5):426-435. doi: 10.1111/ejh.13036. Epub 2018 Feb 27.
10
Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies.CD44的多态性影响血液系统恶性肿瘤患者CD34(+)细胞动员的疗效。
Biol Blood Marrow Transplant. 2014 Jul;20(7):986-91. doi: 10.1016/j.bbmt.2014.03.019. Epub 2014 Mar 27.

引用本文的文献

1
Exploring the potential of predicted miRNAs on the genes involved in the expansion of hematopoietic stem cells.探索预测 microRNAs 在参与造血干细胞扩增的基因中的作用。
Sci Rep. 2024 Jul 5;14(1):15551. doi: 10.1038/s41598-024-66614-9.
2
MicroRNA target homeobox messenger RNA in HIV induced hematopoietic inhibition.微小RNA靶向同源框信使核糖核酸在HIV诱导的造血抑制中发挥作用。
Front Cell Dev Biol. 2024 Apr 24;12:1382789. doi: 10.3389/fcell.2024.1382789. eCollection 2024.
3
Exosomal microRNA following severe trauma: Role in bone marrow dysfunction.

本文引用的文献

1
The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.微小RNA在惰性B细胞非霍奇金淋巴瘤中的多方面作用及应用
Biomedicines. 2021 Mar 25;9(4):333. doi: 10.3390/biomedicines9040333.
2
Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background.多发性骨髓瘤骨病:微小 RNA 在其分子背景中的作用。
Int J Mol Sci. 2021 Feb 27;22(5):2375. doi: 10.3390/ijms22052375.
3
MicroRNA-21 and microRNA-155 promote the progression of Burkitt's lymphoma by the PI3K/AKT signaling pathway.微小RNA-21和微小RNA-155通过PI3K/AKT信号通路促进伯基特淋巴瘤的进展。
严重创伤后的外泌体 microRNA:在骨髓功能障碍中的作用。
J Trauma Acute Care Surg. 2024 Apr 1;96(4):548-556. doi: 10.1097/TA.0000000000004225. Epub 2023 Dec 28.
4
MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.骨髓和淋巴结中 B 细胞淋巴瘤的 microRNA 表达谱。
Int J Mol Sci. 2023 Oct 11;24(20):15082. doi: 10.3390/ijms242015082.
5
A state-of-the-art review on the MicroRNAs roles in hematopoietic stem cell aging and longevity.关于 MicroRNAs 在造血干细胞衰老和长寿中的作用的最新综述。
Cell Commun Signal. 2023 Apr 24;21(1):85. doi: 10.1186/s12964-023-01117-0.
6
Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells.缺氧迅速诱导内皮细胞中一大组差异表达基因的变化。
Int J Mol Sci. 2023 Mar 8;24(6):5157. doi: 10.3390/ijms24065157.
7
SIRT1-SIRT7 Expression in Patients with Lymphoproliferative Disorders Undergoing Hematopoietic Stem Cell Mobilization.造血干细胞动员的淋巴增殖性疾病患者中SIRT1 - SIRT7的表达
Cancers (Basel). 2022 Feb 25;14(5):1213. doi: 10.3390/cancers14051213.
Int J Clin Exp Pathol. 2020 Jan 1;13(1):89-98. eCollection 2020.
4
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma.miR-155 的替代在多发性骨髓瘤中引发肿瘤抑制活性并拮抗硼替佐米耐药性。
Cancers (Basel). 2019 Feb 18;11(2):236. doi: 10.3390/cancers11020236.
5
Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma.多发性骨髓瘤患者外周血造血干细胞采集的最佳化疗动员。
BMC Cancer. 2019 Jan 14;19(1):59. doi: 10.1186/s12885-019-5285-1.
6
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.考博马林,一种 miR-155 的寡核苷酸抑制剂,协调调节多种存活途径,减少皮肤 T 细胞淋巴瘤中的细胞增殖和存活。
Br J Haematol. 2018 Nov;183(3):428-444. doi: 10.1111/bjh.15547. Epub 2018 Aug 20.
7
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.微小RNA生物合成、作用机制及循环概述
Front Endocrinol (Lausanne). 2018 Aug 3;9:402. doi: 10.3389/fendo.2018.00402. eCollection 2018.
8
MicroRNA miR-223 as regulator of innate immunity.miR-223 作为先天免疫的调节因子。
J Leukoc Biol. 2018 Sep;104(3):515-524. doi: 10.1002/JLB.3MR0218-079R. Epub 2018 Jul 3.
9
MicroRNA‑155 contributes to the occurrence of epilepsy through the PI3K/Akt/mTOR signaling pathway.微小 RNA-155 通过 PI3K/Akt/mTOR 信号通路促进癫痫的发生。
Int J Mol Med. 2018 Sep;42(3):1577-1584. doi: 10.3892/ijmm.2018.3711. Epub 2018 Jun 1.
10
Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma.循环miR-155的过表达可预测弥漫性大B细胞淋巴瘤的预后。
Leuk Res. 2018 Jul;70:45-48. doi: 10.1016/j.leukres.2018.05.006. Epub 2018 May 21.